Free Trial

Pheton (PTHL) Competitors

Pheton logo
$0.67 +0.02 (+2.63%)
Closing price 08/14/2025 04:00 PM Eastern
Extended Trading
$0.66 -0.01 (-1.66%)
As of 08/14/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PTHL vs. ALUR, NXGL, NRXS, NXL, IINN, XAIR, BDMD, OSRH, DHAI, and MHUA

Should you be buying Pheton stock or one of its competitors? The main competitors of Pheton include Allurion Technologies (ALUR), NexGel (NXGL), NeurAxis (NRXS), Nexalin Technology (NXL), Inspira Technologies OXY B.H.N. (IINN), Beyond Air (XAIR), Baird Medical Investment (BDMD), OSR (OSRH), DIH Holding US (DHAI), and Meihua International Medical Technologies (MHUA). These companies are all part of the "medical equipment" industry.

Pheton vs. Its Competitors

Pheton (NASDAQ:PTHL) and Allurion Technologies (NYSE:ALUR) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership, media sentiment and valuation.

Pheton has higher earnings, but lower revenue than Allurion Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pheton$450K9.75-$660KN/AN/A
Allurion Technologies$32.11M0.58-$26.15M-$12.50-0.20

Pheton has a net margin of 0.00% compared to Allurion Technologies' net margin of -86.05%.

Company Net Margins Return on Equity Return on Assets
PhetonN/A N/A N/A
Allurion Technologies -86.05%N/A -41.49%

Allurion Technologies has a consensus target price of $22.83, suggesting a potential upside of 820.70%. Given Allurion Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Allurion Technologies is more favorable than Pheton.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pheton
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Allurion Technologies
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.00

21.4% of Allurion Technologies shares are owned by institutional investors. 22.4% of Allurion Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Allurion Technologies had 11 more articles in the media than Pheton. MarketBeat recorded 12 mentions for Allurion Technologies and 1 mentions for Pheton. Pheton's average media sentiment score of 1.88 beat Allurion Technologies' score of 0.00 indicating that Pheton is being referred to more favorably in the media.

Company Overall Sentiment
Pheton Very Positive
Allurion Technologies Neutral

Summary

Allurion Technologies beats Pheton on 8 of the 13 factors compared between the two stocks.

Get Pheton News Delivered to You Automatically

Sign up to receive the latest news and ratings for PTHL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PTHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PTHL vs. The Competition

MetricPhetonMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$4.28M$7.54B$5.61B$9.84B
Dividend YieldN/A2.71%4.61%4.07%
P/E RatioN/A72.1630.2925.74
Price / Sales9.7529.89463.41115.83
Price / CashN/A26.7338.2159.48
Price / Book0.7118.428.826.15
Net Income-$660K$243.10M$3.25B$265.06M
7 Day Performance-21.52%2.82%3.70%2.60%
1 Month Performance-96.76%2.66%5.84%2.83%
1 Year PerformanceN/A20.03%29.92%25.58%

Pheton Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PTHL
Pheton
N/A$0.67
+2.6%
N/AN/A$4.28M$450K0.0011Positive News
Gap Up
ALUR
Allurion Technologies
2.6283 of 5 stars
$2.85
+2.9%
$22.83
+701.2%
-85.9%$20.62M$32.11M-0.23501News Coverage
Short Interest ↓
Analyst Revision
NXGL
NexGel
1.3944 of 5 stars
$2.60
+1.2%
N/A-21.5%$19.67M$8.69M-5.7810News Coverage
Earnings Report
Upcoming Earnings
Short Interest ↓
Gap Up
NRXS
NeurAxis
2.8442 of 5 stars
$2.52
+0.8%
$7.00
+177.8%
-24.7%$18.18M$2.93M-1.3719Short Interest ↑
Gap Up
NXL
Nexalin Technology
3.1052 of 5 stars
$0.99
+0.5%
$5.00
+403.3%
-18.2%$16.99M$131.07K-1.203Short Interest ↓
Gap Up
IINN
Inspira Technologies OXY B.H.N.
3.3136 of 5 stars
$1.31
+6.5%
$2.00
+52.7%
+20.7%$15.52MN/A0.0020Short Interest ↓
XAIR
Beyond Air
3.708 of 5 stars
$2.85
-0.3%
$23.67
+730.4%
-71.0%$13.27M$3.70M-0.1870Earnings Report
Analyst Forecast
Short Interest ↑
Analyst Revision
Gap Down
BDMD
Baird Medical Investment
N/A$1.89
-1.0%
N/AN/A$12.57MN/A0.00N/APositive News
Gap Up
OSRH
OSR
N/A$0.66
+2.0%
N/AN/A$12.38M-$148.95K0.00N/AEarnings Report
DHAI
DIH Holding US
0.4932 of 5 stars
$0.25
-1.3%
N/A-90.6%$11.80M$64.47M-0.82N/AShort Interest ↑
MHUA
Meihua International Medical Technologies
0.7914 of 5 stars
$0.38
+3.0%
N/A-39.7%$11.78M$96.91M0.00620Short Interest ↑

Related Companies and Tools


This page (NASDAQ:PTHL) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners